OraSure Technologies Stock

OraSure Technologies FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of OraSure Technologies (OSUR) as of Aug 16, 2026 is 0.08 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was -120.91 % — a change of -100.06% (higher).

FCF Conversion

0.08 %

YoY

-100.06%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of OraSure Technologies is 2026 0.08 % . FCF Conversion Rate (FCF/EBITDA) of OraSure Technologies was 2025 -120.91 % . It decreases by -100.06% higher compared to the previous year.
Access this data via the Eulerpool API

OraSure Technologies Stock analysis

What does OraSure Technologies do? OraSure Technologies Inc. is a US company specializing in the development, manufacturing, and marketing of diagnostic medical products. It was founded in 1987 under the name SolarCare Technologies Corporation and changed its name to OraSure Technologies Inc. in 2000. The company's main goal is to reduce the prevalence of infectious diseases and improve global health. It focuses on four core areas: infectious diseases, microfluidic analysis, application management, and genomics. In the field of infectious diseases, OraSure Technologies Inc. produces various rapid tests for detecting diseases such as HIV, Hepatitis C, and Syphilis. It also offers tests for drug and alcohol consumption verification. In microfluidic analysis, the company produces devices and test kits for biomedical research and clinical use. These technologies allow for the quick analysis of small samples and accurate results. Application management is another important aspect of the company, offering cloud-based applications for optimized data and information management. These applications help businesses and institutions obtain real-time data and use data analytics tools. Additionally, OraSure Technologies Inc. is involved in genomics and offers various products and services related to DNA sequencing. The company has a broad customer base, ranging from government agencies and research institutions to service companies and private clinics. It operates in numerous countries worldwide. An example of a product from OraSure Technologies is the OraQuick HIV self-test, which allows individuals to determine within 20 minutes whether they are infected with the HIV virus or not. This is particularly important for people who cannot or do not want to visit a doctor and value their privacy. OraSure Technologies' history is marked by numerous innovations and significant milestones. One notable event was the development of the first oral HIV rapid test in 2004, which allowed for quick and reliable detection of the virus through a saliva sample instead of a blood sample. In recent years, the company has increased its investment in research and development and formed partnerships with companies and institutions to bring innovative diagnostic medical products to the market. In summary, OraSure Technologies Inc. is a leading US company specializing in the development, manufacturing, and marketing of diagnostic medical products. With a focus on infectious diseases, microfluidic analysis, application management, and genomics, the company has a wide range of products and a broad customer base. OraSure Technologies is an innovative company striving to improve global health through partnerships and investments in research and development. OraSure Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about OraSure Technologies stock

FCF Conversion Rate (FCF/EBITDA) of OraSure Technologies is 0.08 % in 2026.

FCF Conversion Rate (FCF/EBITDA) of OraSure Technologies changed from -120.91 % to 0.08 %, representing a -100.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) OraSure Technologies since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s OraSure Technologies with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

Cash Flow — OraSure Technologies

All Key Metrics — OraSure Technologies